BMT CTN Protocol 1203 (PROGRESS I)

A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls.

Below are protocol-related documents, which may be periodically updated.

            Protocol Co-Chair: Javier Bolanos-Meade, MD (410-614-0738) fbolano2@jhmi.edu

            Protocol Co-Chair: John Koreth, MD (617-632-2949) John_Koreth@dfci.harvard.edu

            Protocol Co-Chair: Ran Reshef , MD rr3036@columbia.edu

            Protocol Officer: Marcelo Pasquini, MD (414-805-0700) mpasquini@mcw.edu

            Protocol Coordinator: Terry Pritchard (301-251-1161) tpritchard@emmes.com

            Medical Monitor: Shannon Smiley, MD slsmiley@anthc.org

                   

The BMT CTN is committed to including widespread transplant community participation in these trials. However, affiliate center applications are not currently being accepted for this study.